Insomnia Market Insights, Leading Players and Forecast to 2028

1. Global Insomnia Industry Analysis Global Insomnia Market 2028 Outlook Report Insomnia is a common sleep disorder characterized by difficulties in sleep. Insomnia can exist as alone or conjugated with other psychiatric problems. The exact reason for the cause of insomnia is still unknown. It is most common in women and the severity may increase in conditions like postpartum, menopause and pregnancy. Insomnia disorder can be diagnosed in sleep laboratories using various diagnostic devices. Based on the types of therapy, the over-the-counter sleep aids segment is going to have lucrative growth during the forecast period attributing to the growth of this market includes easier availability, low prices, and publicity regarding the side effects of the prescription sleep aids has also steered the patients towards over-the-counter sleep aid. Request for Customization of “Insomnia - Global Market Outlook (2020-2028)” @ https://www.strategymrc.com/report/insomnia-market/request-customization What our report offers: - Market share assessments for the regional and country-level segments - Strategic recommendations for the new entrants - Covers Market data for the years 2019, 2020, 2021, 2025, and 2028 - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements Some of the key players profiled in the Insomnia Market include Merck & Co. Inc., Sanofi, Takeda Pharmaceutical Company Ltd., Purdue Pharmaceuticals L.P., Eisai, Co. Ltd., Meda Consumer Healthcare Inc., Pernix Therapeutics, Vanda Pharmaceuticals, Mallinckrodt Pharmaceuticals, Sumitomo Dainippon Pharma Co., Ltd, Teva Pharmaceutical Industries Ltd., ECR Pharmaceuticals Co Inc, and Pfizer. About Us: StrategyMRC research reports and publications are routed to help clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects. We track 30+ industries and cover 800 market segments. Call Us: +1-301-202-5929 Email: info@strategymrc.com

2. Global Insomnia Industry Analysis Report Coverage Details 2021 Published Year: USD 4,825.17 million Estimated Market Size in 2020: 2020 Estimated Period: Compound Annual Growth Rate (CAGR) from 2020 to 2028: 6.2% USD 7,807.44 million Predicted 2028 Value: 2021-2028 Forecast Years: Tables, Graphs & Figures 278 Type of Diseases, Route of Administration, Application, Drug Formulation, Drug Formulation, Types of Therapy, End User, Distribution Channel • Presence of large undiagnosed insomnia population pool Chapters Covered: Emergence of therapeutics with fewer side-effects • Core Drivers and Opportunities: Rise in demand for OTC sleep aids • Side effects of drugs • Restraining Factors & Market Threats: Rise in number of patent expiration of branded prescription drugs • View complete “Insomnia - Global Market Outlook (2020-2028)” report @ https://www.strategymrc.com/report/insomnia-market Contact Us: Stratistics Market Research Consulting Phone: +1-301-202-5929 Email: info@strategymrc.com Website: https://www.strategymrc.com/ Visit our Blog: https://strategymrc.blogspot.com/ Call Us: +1-301-202-5929 Email: info@strategymrc.com